<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Team on Radiomics</title><link>/team/</link><description>Recent content in Team on Radiomics</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Sat, 10 Feb 2018 11:52:18 +0700</lastBuildDate><atom:link href="/team/index.xml" rel="self" type="application/rss+xml"/><item><title>Raquel Perez-Lopez</title><link>/team/raquel/</link><pubDate>Sun, 18 Nov 2018 12:33:46 +1000</pubDate><guid>/team/raquel/</guid><description>Raquel Perez-Lopez is the team leader of the Radiomics Group at VHIO, and consultant Radiologist at Vall d&amp;rsquo;Hebron Hospital, within the Vall d&amp;rsquo;Hebron Barcelona Hospital Campus. Her work aims to develop novel non-invasive imaging biomarkers in oncology to improve cancer patient care.
Scientific trajectory Dr Raquel Perez-Lopez is an experienced academic radiologist trained at Bellvitge University Hospital in Barcelona (Spain) and the Royal Marsden Hospital and the Institute of Cancer Research in London (UK).</description></item><item><title>Kinga Bernatowicz</title><link>/team/kinga/</link><pubDate>Sun, 18 Nov 2018 12:33:46 +1000</pubDate><guid>/team/kinga/</guid><description>Driven by scientific curiosity, Kinga has gained a broad range of expertise in engineering, medical physics and environmental science. She joined the Radiomics Group in November 2019 and has focused on investigating tumor heterogeneity and integrating multi-omics data in predictive models for immunotherapy.
Scientific trajectory Her academic journey started at Gdańsk University of Technology, where she obtained an engineering degree (B.Sc. in Environmental Protection and Management). She had always been interested in physics and soon after received her M.</description></item><item><title>Francesco Grussu</title><link>/team/francesco/</link><pubDate>Sun, 18 Nov 2018 12:33:46 +1000</pubDate><guid>/team/francesco/</guid><description>Francesco joined VHIO in 2020. His research aims to develop novel Magnetic Resonance Imaging (MRI) techniques for liver microstructure measurement, potentially useful in oncology. He is also involved in designing MRI acquisition and analysis pipelines in the clinical studies of the Radiomics Group.
Scientific trajectory Francesco is a biomedical engineer specialised in computational MRI, with almost 10 years of experience in MRI research. He graduated from the University of Cagliari (BEng Biomedical engineering, 2009) and University of Genoa (MEng Bioengineering, 2012), Italy.</description></item><item><title>Alonso Garcia-Ruiz</title><link>/team/alonso/</link><pubDate>Wed, 28 Nov 2018 15:15:26 +1000</pubDate><guid>/team/alonso/</guid><description>Alonso is a biomedical engineer and has been member of the Radiomics team since 2018. He is currently pursuing his PhD, working on whole-body diffusion MRI as a biomarker of bone metastases, and on brain perfusion MRI for tumour characterization. Scientific trajectory In 2014, he obtained his B.Sc. at Universidad Carlos III de Madrid and his M.Sc. at Katholieke Universiteit Leuven in 2017, focusing on image processing, but also glancing at medical image acquisition, computer vision and machine learning within the healthcare context.</description></item><item><title>Marta Ligero</title><link>/team/marta/</link><pubDate>Wed, 28 Nov 2018 15:15:34 +1000</pubDate><guid>/team/marta/</guid><description>Marta is a biomedical engineer who joined the Radiomics group in 2018. She&amp;rsquo;s focused on the implementation of artificial intelligence for developing CT-based radiomics biomarkers of response to immunotherapy. She also has research interest in radiomics variability and biological translation.
Scientific trajectory Marta is a PhD student with expertise in artificial intelligence algorithms for medical imaging applications, especially on CT-based radiomics for predicting response to treatment. Marta graduated in Biomedical Engineering (2017) from the University of Barcelona (UB) and received her M.</description></item><item><title>Olivia Prior Palomares</title><link>/team/olivia/</link><pubDate>Wed, 28 Nov 2018 15:14:54 +1000</pubDate><guid>/team/olivia/</guid><description>Olivia is a biomedical engineer who joined VHIO in 2021. Her research is focused on new imaging biomarkers identification and intratumor/microenvironment heterogeneity exploration. Scientific trajectory Olivia obtained a BS. in Biomedical Engineering from Universitat de Barcelona (2018). As part of her final degree project, she worked at the International Centre for Numeric Methods at Universitat Politècnica de Catalunya under the supervision of Dr. Eduardo Soudah, where she contributed to the development of an augmented reality system for oncological surgeries.</description></item><item><title>Camilo Monreal</title><link>/team/camilo/</link><pubDate>Wed, 28 Nov 2018 15:14:39 +1000</pubDate><guid>/team/camilo/</guid><description>Camilo is a Computer Scientist with a Master in Logic and AI who joined the Radiomics group in 2021. One of his main roles in the group is to provide support in the group’s computational cluster while enabling the development and implementation of final end-user applications.</description></item><item><title>Andreu Antolin</title><link>/team/andreu/</link><pubDate>Sun, 18 Nov 2018 12:33:46 +1000</pubDate><guid>/team/andreu/</guid><description>Andreu is a radiology resident at Hospital Vall d&amp;rsquo;Hebron (Barcelona). He joined the Radiomics Group in mid-2021 and gives support to the team in specific tasks such as image interpretation, labeling and radiomics-based model development. He is interested in the application of AI in the field of Radiology using Machine Learning and Deep Learning methods.</description></item><item><title>Maria Balaguer</title><link>/team/maria/</link><pubDate>Wed, 28 Nov 2018 15:15:34 +1000</pubDate><guid>/team/maria/</guid><description>Maria is a biomedical engineer student who joined the Radiomics group in 2021. She&amp;rsquo;s focusing her final degree project on developing PET-CT-based radiomics signatures to predict response in patients with non-Hodgkin&amp;rsquo;s Lymphoma treated with CART T-cells.</description></item></channel></rss>